Discover
RNAZ
TransCode Therapeutics, Inc.
7.65
2 x 5.69
2 x 9.63
bid
ask
+
1.44
23.19%
2 @ 04:00 PM
7.49 -0.16 (2.09%)
| Ytd | 12.01% | |
| 1y | 2.00% |
6.25
day range
7.97
3.82
52 week range
20.99
| Open | 6.25 | Prev Close | 6.21 | Low | 6.25 | High | 7.97 | Mkt Cap | 7.27M |
| Vol | 66.75K | Avg Vol | 54.63K | EPS | -3.71 | P/E | N/A | Forward P/E | -5.97 |
| Beta | 0.65 | Short Ratio | 0.50 | Inst. Own | 1.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 6.36 | 200-d Avg | 8.93 | 1yr Est | 20.00 |
RNAZ News
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1
TransCode Therapeutics announced successful completion of Phase 1a clinical trial for TTX-MC138, sho
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session